Composition for treating oral mucositis comprising a nitric oxide complex, and a therapeutic agent for oral mucositis

Composition for the treatment of oral mucositis containing a nitric oxide complex

This technology is a composition and therapeutic agent for treating oral mucositis, comprising a nitric oxide complex.

Oral mucositis, often induced by cancer treatment, significantly impairs patients' quality of life, yet effective treatment has been challenging.

The nitric oxide complex in this technology activates human gingival fibroblasts (HGF-1) and promotes wound healing, vasodilation, angiogenesis, and immune function, thereby improving the healing of oral mucosa.

‍

‍

Key Features:

• Therapeutic composition containing a nitric oxide complex
• Activation of human gingival fibroblasts (HGF-1)
• Promotion of wound healing, vasodilation, and angiogenesis
• Improved healing of oral mucositis